Page last updated: 2024-08-23

buserelin and Impotence

buserelin has been researched along with Impotence in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Petas, A; Pettersson, B; Sandow, J; Varenhorst, E	1
de Voogt, HJ	1
Nillius, SJ	1

Reviews

1 review(s) available for buserelin and Impotence

Article	Year
Gonadotrophin-releasing hormone agonists for new approaches to contraception in man. Wiener klinische Wochenschrift, 1985, Dec-06, Volume: 97, Issue:23 Topics: Abortion, Induced; Administration, Intranasal; Breast Neoplasms; Buserelin; Contraception; Corpus Luteum; Erectile Dysfunction; Female; Hormones; Humans; Male; Norethindrone; Oligospermia; Ovulation; Pituitary Hormone-Releasing Hormones; Risk; Testosterone	1985

Article

Year

Gonadotrophin-releasing hormone agonists for new approaches to contraception in man.

Wiener klinische Wochenschrift, 1985, Dec-06, Volume: 97, Issue:23

Topics: Abortion, Induced; Administration, Intranasal; Breast Neoplasms; Buserelin; Contraception; Corpus Luteum; Erectile Dysfunction; Female; Hormones; Humans; Male; Norethindrone; Oligospermia; Ovulation; Pituitary Hormone-Releasing Hormones; Risk; Testosterone

1985

Trials

2 trial(s) available for buserelin and Impotence

Article	Year
Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study. European urology, 2006, Volume: 50, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Buserelin; Carcinoma; Combined Modality Therapy; Drug Administration Routes; Drug Implants; Erectile Dysfunction; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Libido; Male; Middle Aged; Neoadjuvant Therapy; Prostate; Prostatic Neoplasms; Sexual Behavior; Testosterone; Time Factors	2006
[Prostate cancer; hormonal treatment in a new stage?]. Nederlands tijdschrift voor geneeskunde, 1986, Apr-26, Volume: 130, Issue:17 Topics: Aged; Buserelin; Clinical Trials as Topic; Erectile Dysfunction; Flushing; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms	1986

Article

Year

Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.

European urology, 2006, Volume: 50, Issue:3

Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Buserelin; Carcinoma; Combined Modality Therapy; Drug Administration Routes; Drug Implants; Erectile Dysfunction; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Libido; Male; Middle Aged; Neoadjuvant Therapy; Prostate; Prostatic Neoplasms; Sexual Behavior; Testosterone; Time Factors

2006

[Prostate cancer; hormonal treatment in a new stage?].

Nederlands tijdschrift voor geneeskunde, 1986, Apr-26, Volume: 130, Issue:17

Topics: Aged; Buserelin; Clinical Trials as Topic; Erectile Dysfunction; Flushing; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms

1986